Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia

Article Properties
  • Language
    English
  • DOI (url)
    10.2217/14750708.3.3.383
  • Publication Date
    2006/05/01
  • Journal
    Therapy
  • Indian UGC (journal)
  • Refrences
    12
  • Iqbal S Shergill
  • Jayanta M Barua
Cite
Shergill, Iqbal S, and Jayanta M Barua. “Dutasteride: 21st Century Medical Therapy for Symptomatic Benign Prostatic Hyperplasia”. Therapy, vol. 3, no. 3, 2006, pp. 383-6, https://doi.org/10.2217/14750708.3.3.383.
Shergill, I. S., & Barua, J. M. (2006). Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia. Therapy, 3(3), 383-386. https://doi.org/10.2217/14750708.3.3.383
Shergill IS, Barua JM. Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia. Therapy. 2006;3(3):383-6.
Refrences
Title Journal Journal Categories Citations Publication Date
Chemoprevention using dutasteride: the REDUCE trial Current Opinion in Urology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
 27 2005
Chemoprevention using dutasteride: the REDUCE trial
10.1016/S1569-9056(06)60698-2
10.1016/S1569-9056(06)60699-4
10.1016/S1569-9056(06)60697-0